8-K//Current report
Ultragenyx Pharmaceutical Inc. 8-K
Accession 0000950170-25-103026
$RARECIK 0001515673operating
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:07 PM ET
Size
537.2 KB
Accession
0000950170-25-103026
Documents
- 8-Krare-20250805.htmPrimary
8-K
- EX-99.1rare-ex99_1.htm
EX-99.1
- GRAPHICimg45776771_0.jpg
GRAPHIC
- EX-101.SCHrare-20250805.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-103026-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLrare-20250805_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001515673
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 4:07 PM ET
- Size
- 537.2 KB